{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:44:27Z","timestamp":1792082667202,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.humpath.2022.01.001","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T02:13:42Z","timestamp":1642644822000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Immunohistochemistry for LEF1 and SOX11 adds diagnostic specificity in small B-cell lymphomas"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5784-5368","authenticated-orcid":false,"given":"Aruna","family":"Rangan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Reinig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen D.","family":"McPhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Rech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.01.001_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.humpath.2022.01.001_bib2","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood-2010-02-269878","article-title":"LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis","volume":"116","author":"Gutierrez","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.01.001_bib3","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2011.103","article-title":"Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia\/small lymphocytic lymphoma in small B-cell lymphomas","volume":"24","author":"Tandon","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.01.001_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jclinpath-2015-202862","article-title":"LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia\/small lymphocytic B cell lymphoma","volume":"68","author":"Menter","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.01.001_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MOH.0000000000000434","article-title":"SOX11, a key oncogenic factor in mantle cell lymphoma","volume":"25","author":"Beekman","year":"2018","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.humpath.2022.01.001_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-017-0598-1","article-title":"Role of SOX11 and genetic events cooperating with cyclin D1 in mantle cell lymphoma","volume":"19","author":"Bea","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.humpath.2022.01.001_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40364-016-0060-9","article-title":"SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma","volume":"4","author":"Narurkar","year":"2016","journal-title":"Biomark Res"},{"key":"10.1016\/j.humpath.2022.01.001_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.anndiagpath.2016.09.016","article-title":"Expression of LEF1 in mantle cell lymphoma","volume":"26","author":"O'Malley","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2022.01.001_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/ajcp\/aqz207","article-title":"Immunohistochemical expression of lymphoid enhancer binding factor 1 in CD5-positive marginal zone, lymphoplasmacytic, and follicular lymphomas","volume":"153","author":"Patel","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.01.001_bib10","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ajpath.2012.12.013","article-title":"Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt's lymphoma","volume":"182","author":"Walther","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2022.01.001_bib11","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.5858\/arpa.2014-0058-RA","article-title":"New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma","volume":"138","author":"Zhang","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2022.01.001_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3109\/10428194.2013.815353","article-title":"Indolent mantle cell lymphoma","volume":"55","author":"Hsi","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2022.01.001_bib13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2022.01.001_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PAS.0b013e318241f050","article-title":"Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression","volume":"36","author":"Zeng","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.01.001_bib15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/PAS.0000000000001233","article-title":"SOX11-negative mantle cell lymphoma: clinicopathologic and prognostic features of 75 patients","volume":"43","author":"Xu","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.01.001_bib16","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/modpathol.2015.99","article-title":"Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype","volume":"28","author":"Ribera-Cortada","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.01.001_bib17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/PAI.0000000000000067","article-title":"Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders","volume":"22","author":"Nakashima","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2022.01.001_bib18","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/leu.2012.72","article-title":"Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease","volume":"26","author":"Royo","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2022.01.001_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.humpath.2016.09.018","article-title":"Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients","volume":"59","author":"Righi","year":"2017","journal-title":"Hum Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:39:24Z","timestamp":1758645564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":19,"alternative-id":["S0046817722000119"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.01.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemistry for LEF1 and SOX11 adds diagnostic specificity in small B-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}